Abstract:Objective:To evaluate the in vivo antibacterial effects of combination of sulbactam with cefotaxim(1;1,2;1,4:1 and 8:1)in the treatment of mice septicemia caused by the pathogenic microor- ganisms producing extended-spectrum beta-lactamases(ESBLs).Methods;A mouse septicemia model was set up by an abdominal injection with 0.5 mL minimum lethal dose of methicillin-resistant Staphylococcus aureus(MRSA),Escherichia coli(E.coli),KlebsieUa pneumoniae(Kl.pneumoniae)and Enterobacter cloacae (Ent.cloacae).The different concentrations of combination antibiotics(0.2 mL each injection)were in- jected once into the mice in 1 hour after the injection of bacteria.Each combination antibiotics were tested in 5～6 concentration groups,and each group was consisted of 10 mice.The death rate in each infected mice group was monitored.The ED_(50),ED_(95_)and L_(95)were calculated using a bliss method of NDST software. The t test was used to determine the statistical significance of ED_(50).Results;The combination of cefotaxim with sulbactam at the ratio of 1:1,2;1 and 4:1 showed a superiority against E.coli,Kl,pneumoniae and Ent. cloacae to the one at 1;8 and cefotaxim alone,the ED_(50)and ED_(95)values of the combination of sulbactam with cefotaxim(1:1,2:1 and 4:1)against the mouse septicemia by E.coli and Kl.pneumoniae were 1/6.6～1/2.0 and 1/6.9～1/1.4 times of cefotaxim alone(P＜0.01).The combination of sulbactam with cefotaxim(1:1 and 2;1)against the mouse septicemia by Ent.cloacae were 1/5.2～1/4.2 and 1/3.6～1/2.0 times of the ones at the ratio of 4:1 and 8:1 and cefotaxim alone(P＜0.01).The combination of sulbactam with cefotaxim(1;1,2;1,4:1 and 8;1)against the mouse septicemia by MRSA showed no difference from cefotaxim alone(P＞0.05).Conclusion;The combination of sulbactam with cefotaxim (1:1 and 1:2)had the most potent antibacterial activity.In the viewpoint of the combination,the optimal ratio of sulbactam to cefotaxim is 1:2.

Study on the Amoxillin-Tylosin Tartrate Compound Against Streptococcos Suis in Mice

The in Vivo Antibacterial Activity of Amoxicillin-Clavulanic Acid in Mouse Septicemia Model

Comparative Study on Antibacterial Activity of Amoxicillin and Piperacillin

Antibacterial Activities of Different Concentration Ratio of Cefotaxim-Sulbactam Against the Pathogenic Microorganisms

Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus Suis Infection

Apigenin and Ampicillin as Combined Strategy to Treat Severe Streptococcus suis Infection

Prevention and Treatment of Chinese Herbal Preparation Yinqiaotiangan Against Pathologic Model of Streptococcus Suis Serotype II in Kunming Mice

Synergistic Activity of Tienam and Netilmycin in a Combination Therapy in Experimental MRSA Infection of Mice

Study on the Effect of Phillyrin on Streptococcus suis In Vivo and In Vitro

Application of S-thanatin, an Antimicrobial Peptide Derived from Thanatin, in Mouse Model of Klebsiella Pneumoniae Infection

Preventive and Therapeutic Effects of Suramin on Lipopolysaccharide-Induced Mouse Model of Acute Lung Injury and Its Molecular Mechanism

Sub-MICs of Azithromycin Decrease Biofilm Formation of Streptococcus suis and Increase Capsular Polysaccharide Content of S. suis

[Inhibitory Effect of Suramin on Inflammatory Response in Pulmonary Tissue and Peripheral Blood in LPS-induced Septic Mice].

Pharmacodynamic Target Assessment and PK/PD Cutoff Determination for Gamithromycin Against Streptococcus Suis in Piglets

Genetic and Virulence Characterization of Streptococcus Suis Type 2 Isolates from Swine in the Provinces of Zhejiang and Henan, China

Theaflavin Ameliorates Streptococcus suis-Induced Infection In Vitro and In Vivo

In vitro activity of sultamicillin against clinical isolates from China

The bacteriocin sublancin attenuates intestinal injury in young mice infected with Staphylococcus aureus

Application Of The Phage Lysin Ply5218 In The Treatment Of Streptococcus Suis Infection In Piglets

Inhibition of Suilysin Activity and Inflammation by Myricetin Attenuates Streptococcus Suis Virulence

Isopropoxy Benzene Guanidine Ameliorates Streptococcus suis Infection In Vivo and In Vitro